Creative Planning’s Allergan plc AGN Stock Holding History

Creative Planning’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-700	Closed	-$5K	–	2154
2019 Q3	$5K	Hold	700	–	–	﹤0.01%	1926
2019 Q2	$6K	Hold	700	–	–	﹤0.01%	1956
2019 Q1	$4K	Hold	700	–	–	﹤0.01%	1921
2018 Q4	$4K	Hold	700	–	–	﹤0.01%	1879
2018 Q3	$25K	Buy	+700	New	+$129K	﹤0.01%	1935
2017 Q2	–	Sell	-300	Closed	-$1K	–	4946
2017 Q1	$1K	Buy	+300	New	+$69.9K	﹤0.01%	4550
2016 Q4	–	Sell	-800	Closed	-$2K	–	4957
2016 Q3	$2K	Buy	800 +500	+167%	+$122K	﹤0.01%	4297
2016 Q2	$3K	Buy	+300	New	+$69.2K	﹤0.01%	3940
2014 Q4	–	Sell	-500	Closed	-$17K	–	4421
2014 Q3	$17K	Sell	500 -500	-50%	-$112K	﹤0.01%	2645
2014 Q2	$24K	Hold	1,000	–	–	﹤0.01%	2388
2014 Q1	$19K	Buy	+1,000	New	+$198K	﹤0.01%	2418

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Creative Planning's AGN Position: Q2 2020 in Review

Creative Planning sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,784 shares — an estimated $1.2M sold.

Creative Planning first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $7.4M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

Creative Planning reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
Creative Planning sold 6,784 Allergan plc shares in Q2 2020, an estimated $1.2M.
Creative Planning first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
Creative Planning's Allergan plc position peaked at $7.4M in Q1 2015.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Creative Planning's 13F filing for Q2 2020, filed 23 Jul 2020.